University of California, Los Angeles
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Los Angeles sits in the top decile of US sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count).
University of California, Los Angeles: 897 sponsored US clinical trials, 158 recruiting.
University of California, Los Angeles sponsors 897 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 622 completed. 98 of these trials are in Phase 3-4 (later-stage) and 194 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of California, Los Angeles ranks in the top decile of sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
622 of 679 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
897 total, page 18 of 18
CBT for Comorbid Anxiety Disorders in Children With Autism, Asperger Syndrome, or PDD-NOS
NCT00280670
Educational Technology to Enhance Diabetes Care - Retention Study
NCT00470860
Transitional Case Management Study
NCT00264329
The Effects of a Dietary Supplement on Exercise Performance in Healthy Older Adults"
NCT01073332
Behavioral Therapy Development for Methamphetamine Abuse
NCT00252434
Constructing an Insulin-Like Growth Factor-based Prediction Model
NCT00263445
Effects of Protein-Enriched Meal on Liver, Kidney or Bone: a Randomized Controlled Trial
NCT01030354
Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy
NCT00389467
Cognitive-Behavioral Therapy and Tai Chi Chih for Patients With Rheumatoid Arthritis
NCT00072657
Nesiritide - Dilated Cardiomyopathy
NCT00709163
Study of Medication and Placebo Response in Major Depression
NCT00229476
Relationship Training for Children With Autism and Their Peers
NCT00095420
Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome
NCT00241215
Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1
NCT00078117
Clinical Evaluation of Morcher Artificial Iris Diaphragms
NCT00812708
Promoting Adherence to Treatment in Schizophrenia
NCT01125267
Electroencephalography (EEG) Biomarkers of Response in Depression
NCT00759122
Celecoxib in Preventing Lung Cancer in Former Heavy Smokers
NCT00055978
Hyperalgesia in Methadone-Maintained Patients: Can it be Treated?
NCT01210079
Rapamycin vs Methotrexate in Diffuse SSc
NCT00241189
Early Surgical Intervention to Treat Epilepsy
NCT00040326
Testosterone Treatment for Multiple Sclerosis
NCT00405353
Estrogen and Perimenopausal Depression
NCT00229450
Study of Genetic Differences in People With Depression
NCT00229463
Animal-Assisted Therapy for Hospitalized Heart Failure Patients
NCT00391456
Evaluating the Effectiveness of Family-Focused Psychoeducation in Treating Adolescents With Bipolar Disorder
NCT00571402
Physiologic Monitoring of Antidepressant Treatment Response
NCT00759317
Online Family Support and Education for Schizophrenia
NCT00046085
Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1
NCT00032955
Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1
NCT00032968
Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs
NCT00065169
Anti-Inflammatory Treatment for Age-Associated Memory Impairment: A Double-Blind Placebo-Controlled Trial
NCT00009230
Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients
NCT00183625
Effects of Parental Behavior on Child Anxiety Regulation
NCT00593515
Improving Work Outcome in People With Recent-onset Schizophrenia
NCT00203788
Study of Ischemic Colitis Compared to Other Diagnoses in Patients With Lower Gastrointestinal Bleeding
NCT01078324
Comparison Between Two Endoscopic Treatments of Bleeding Internal Hemorrhoids:Band Ligation and Electrocoagulation Probe
NCT00630669
Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
NCT00000303
Physiologic Monitoring of Antidepressant Response
NCT00792168
Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4
NCT00000301
Feasibility Study of Take-Home LAAM Medication - 3
NCT00000300
Long-term Observation of Patients With Early Rheumatoid Arthritis
NCT00240136
Multicenter Clinical Trial of Buprenorphine - 3
NCT00000207
Clinical Rescue Protocol - 2
NCT00000206
Buprenorphine Maintenance Protocol - 1
NCT00000205
Natural History of HPV From Infection to Neoplasia in Adolescents and Young Women
NCT01366742
Mentored Patient-Oriented Research Career Development Award
NCT00203684
What is open in the University of California, Los Angeles pipeline
158 recruiting of 897 indexed (18% open); 622 completed (69%).
Phase mix: 98 late (III/IV) vs 194 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Los Angeles: open-pipeline peers nationwide
Peers matched on 897 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 897 trials (± recruiting share)
- Indiana University · 890 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- ConvaTec · 18% recruiting · 17 trials
- Endologix · 18% recruiting · 17 trials
- National Institute on Deafness and Other Communication Disorders (NIDCD) · 18% recruiting · 34 trials
- NICHD Pelvic Floor Disorders Network · 18% recruiting · 17 trials
Related
What to do with this University of California, Los Angeles page
897 registered trials is a research-attention snapshot, not an endorsement of University of California, Los Angeles or any single study.
- 158 of University of California, Los Angeles's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of California, Los Angeles studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Los Angeles pipeline card: 897 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.